Table 1.
Selected drugs of interest during the COVID-19 outbreak and relative changes in their consumption. Consumption (g day−1) and standard deviation of specific drugs and of 7 drug classes and their % change during the same calendar period (March / April 2019–2020) are shown.
| Compound name/classes (number of compounds) | Consumption (g/day) 2019 |
Standard deviation 2019 |
Consumption (g/day) 2020 |
Standard deviation 2020 | Change (%) 2019–2020 |
|---|---|---|---|---|---|
| Hydroxychloroquine | 12 | 1 | 57 | 4 | +387% |
| Antivirals-excluding hydroxychloroquine | 5576 | 453 | 15,010 | 786 | +170% |
| Azithromycin | 2222 | 168 | 3028 | 322 | +36.3% |
| Other antibiotics – excluding azithromycin | 11,987 | 416 | 19,325 | 641 | +61% |
| Paracetamol | 76,044 | 4796 | 226,449 | 21,859 | +198% |
| 11 NSAIDs | 99,250 | 4811 | 72,524 | 3770 | −26.9% |
| Antihypertensives ARBs/ACEis | 106,706 | 2872 | 75,374 | 3510 | −29.4% |
| B-Blockers | 5783 | 311 | 5106 | 331 | −11.7% |
| Antiarrhythmics | 217 | 22 | 156 | 12 | −28.1% |